Calendar VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-12 pm EST			5-day change	1st Jan Change
0.3756 ^USD	-7.28%		+1.51%	-88.79%

Nov. 06	VYNE Therapeutics Q3 net loss narrows, strategic review ongoing	RE
Nov. 06	VYNE Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Chart calendar VYNE Therapeutics Inc.

b.YIrd69EF0lHKsND1cOIl5N3oJFQ-FTD3rcmSZJOvXqs.CL2IrbBAnzmv9rG8XbMSnvCmdThQdFS44a3TVvXEDZIV7buv4lOFMKz6sw~61c4b7834a24a28fbbafc3478b9e097d

Upcoming events on VYNE Therapeutics Inc.

2026-02-25	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-05-06	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-18	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-11-04	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on VYNE Therapeutics Inc.

2025-11-06	Q3 2025 Earnings Release
2025-08-14	Q2 2025 Earnings Release
2025-05-07	Q1 2025 Earnings Release
2025-03-27	H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
2025-03-10	Leerink Partners Global Healthcare Conference
2025-03-06	Q4 2024 Earnings Release
2025-03-04	TD Cowen Healthcare Conference
2024-12-11	Annual General Meeting
2024-11-07	Q3 2024 Earnings Release
2024-09-17	Stifel Immunology and Inflammation Virtual Summit
2024-09-08	H.C. Wainwright Global Investment Conference
2024-08-14	Q2 2024 Earnings Release
2024-07-08	Leerink Partners Therapeutics I&I and Metabolism Forum
2024-05-18	Society for Investigative Dermatology Meeting
2024-05-16	Society for Investigative Dermatology Meeting
2024-05-09	Q1 2024 Earnings Release
2024-03-28	H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
2024-03-07	Global Vitiligo Foundation Scientific Symposium
2024-03-04	TD Cowen Health Care Conference
2024-02-29	Q4 2023 Earnings Release

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	0,48 0,37 30.09%	0,42 0,50 -15.2%	0,50 0,55 -8.91%	0,40	0,23	0,00
EBITDA Million USD	Released Forecast Spread	0,00 0,00 -	-29,3 -29,7 1.49%	-43,6 -45,5 4.1%	-44,0	-50,7	-57,7
EBIT Million USD	Released Forecast Spread	-34,3 -36,6 6.17%	-29,3 -32,2 9%	-43,6 -44,9 2.7%	-32,5	-44,7	-66,4
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-33,9 -30,3 -12.17%	-27,9 -28,7 2.89%	-39,8 -40,5 1.6%	-41,1	-50,3	-66,3
Net income Million USD	Released Forecast Spread	-23,2 -23,8 2.27%	-28,5 -28,7 0.86%	-39,8 -40,5 1.56%	-29,4	-44,1	-66,3
EPS USD	Released Forecast Spread	-7,28 -8,52 14.55%	-2,78 -4,82 42.32%	-0,93 -0,96 3.12%	-0,69	-0,66	-0,64
Announcement Date		09/03/23	29/02/24	06/03/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	0,10 0,10 -2%	0,20 0,11 80%	0,12 0,11 10%	0,08 0,14 -40%	0,20 0,05 304%	0,07 0,15 -54%	0,17 0,10 69%	0,20	0,20	0,20	0,20	0,20
EBITDA Million USD	Released Forecast Spread	-7,38 -8,10 8.89%	-10,4 -8,50 -22.31%	-13,1 -9,70 -34.96%	-12,8 -14,7 13.16%	-9,19 -13,1 29.84%	-7,54 -10,6 28.91%	-11,6	-12,6
EBIT Million USD	Released Forecast Spread				-12,8 -13,4 4.7%	-9,20 -13,0 29.25%	-7,54 -9,40 19.77%	-7,79 -7,70 -1.19%	-7,90	-8,10	-8,30	-8,40	-8,60
Earnings before Tax (EBT) Million USD	Released Forecast Spread		-9,40 -8,10 -15.99%	-12,2 -9,20 -32.14%	-12,0 -12,7 5.06%	-8,60 -13,0 33.82%	-5,75 -10,5 45.27%	-7,43 -11,5 35.43%	-12,5
Net income Million USD	Released Forecast Spread	-6,25	-9,41 -8,10 -16.12%	-12,2 -9,20 -32.14%	-12,0 -12,7 5.04%	-8,61 -12,7 31.98%	-5,76 -9,65 40.33%	-7,28 -5,91 -23.18%	-7,60	-7,70	-7,90	-8,10	-8,20
EPS USD	Released Forecast Spread	-0,15	-0,22 -0,19 -15.79%	-0,29 -0,24 -23.4%	-0,28 -0,30 7.69%	-0,20 -0,29 31.03%	-0,13 -0,22 41.79%	-0,17 -0,13 -30.77%	-0,18	-0,18	-0,18	-0,18	-0,19
Announcement Date		09/05/24	14/08/24	07/11/24	06/03/25	08/05/25	14/08/25	06/11/25	-	-	-	-	-

Upcoming sector events for VYNE Therapeutics Inc.

2025-12-14	SANBIO COMPANY LIMITED	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-14	BIOCON LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-04	ANAVEX LIFE SCIENCES CORP.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-05	GENMAB A/S	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-09	EXELIXIS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-09	ARROWHEAD PHARMACEUTICALS, INC.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-10	VIKING THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-10	REZOLUTE, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-11	AGIOS PHARMACEUTICALS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-11	PROTHENA CORPORATION PLC	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for VYNE Therapeutics Inc.

2025-12-08	LUMOSA THERAPEUTICS CO., LTD.	November 2025 Sales and Revenue Release
2025-12-05	PHARMAESSENTIA CORPORATION	November 2025 Sales and Revenue Release
2025-12-05	TAIMED BIOLOGICS INC.	November 2025 Sales and Revenue Release
2025-12-04	MAPLIGHT THERAPEUTICS, INC.	Q3 2025 Earnings Release
2025-12-03	KALVISTA PHARMACEUTICALS, INC.	Q2 2026 Earnings Release (Projected)
2025-11-25	ARROWHEAD PHARMACEUTICALS, INC.	Q4 2025 Earnings Release
2025-11-21	INVENTIVA	Q3 2025 Sales and Revenue Release
2025-11-17	IMMATICS N.V.	Q3 2025 Earnings Release
2025-11-14	SCHOLAR ROCK HOLDING CORPORATION	Q3 2025 Earnings Release
2025-11-13	ORUM THERAPEUTICS, INC.	Q3 2025 Earnings Release